Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Company type

    Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases

    Funding rounds

    (12 Jan 2010)

    Current and past shareholders